Efficiency of Refracterin in Patients with Chronic Cardiac Insufficiency Caused by Coronary Heart Disease

    loading  Checking for direct PDF access through Ovid

Abstract

Composite preparation refracterin administered in a dose of 300 mg/day for 3 days in addition to routine therapy significantly improved the results of treatment of severe cardiac insufficiency of ischemic genesis compared to placebo. Improvement of clinical status of patients is determined by positive dynamics of systolic and diastolic functions of the left ventricle.

Related Topics

    loading  Loading Related Articles